Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD — Stella

Home/Wet Age-related Macular Degeneration (wAMD)/Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

View on ClinicalTrials.gov

Recruiting

Back to Wet Age-related Macular Degeneration (wAMD) trials

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Trial locations(1 site)

China

Chinese Academy of Medical Sciences & Peking Union Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Beijing Anlong Biopharmaceutical Co., Ltd.

Enrollment target

~21 participants

Started

December 2024

Primary completion

June 2029

Age range

50 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.